Navigation Links
Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
Date:5/3/2012

INDIANAPOLIS, May 3, 2012  /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today applauded law enforcement officials for their successful investigation and the recovery of more than $70 million in pharmaceuticals stolen from its United States distribution center located in Enfield, Connecticut, on Sunday, March 14, 2010.      

"For more than two years, Lilly has cooperated with this criminal investigation – providing important information to federal and local authorities to help piece together the details of the theft," said Maria Crowe, President, Manufacturing Operations, Eli Lilly and Company. 

"We applaud the dedication of the Enfield Police Department, the Federal Bureau of Investigation, Department of Justice prosecutors in New
Haven, Newark, and Miami, and the Miami Organized Crime Drug Enforcement Task Force,  who have worked tirelessly to identify and apprehend those suspected of being involved in the March 2010 burglary," said Crowe.

The pharmaceuticals taken from Lilly's warehouse have been successfully recovered, preventing them from entering pharmaceutical distribution channels.  Lilly plans to destroy the products when they are no longer needed as evidence.

Crowe added that Lilly is committed to partnering with the Food and Drug Administration, law enforcement, and other officials and organizations to help ensure patient safety and the secure distribution of Lilly medicines. 

To that end, in addition to strengthening security for its facilities and pharmaceutical transportation, Lilly is one of seven pharmaceutical companies that formed the Coalition for Patient Safety and Medicine Integrity in 2011. Two primary goals of the coalition are to protect patients from risks posed by stolen and inappropriately handled medical products that enter legitimate distribution channels and increase the associated federal criminal penalties for crimes involving stolen medical products. 

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information ─ for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. C-LLY

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2019)... ... November 14, 2019 , ... ... a Band-Aid that will measure a baby’s blood oxygen levels, a vital indication ... supply. Unlike current systems used in hospitals, this miniaturized wearable device will be ...
(Date:11/14/2019)... TAMPA, Fla. (PRWEB) , ... November 14, 2019 , ... ... research and patient services in Tampa Bay at the 7th Annual Treasure Chests 5K ... put on by the Tampa Bay Buccaneers and powered by Jabil. , “We ...
(Date:11/12/2019)... WASHINGTON (PRWEB) , ... November 12, 2019 , ... ... manufacturers of vinyl, vinyl chloride monomer (VCM), additives, and modifiers, announced recipients of ... the vinyl industry for improving worker safety and protecting the environment at manufacturing ...
Breaking Medicine Technology:
(Date:11/11/2019)... ... ... Early praise for A Nurse’s Step-by-Step Guide to Publishing a Dissertation or DNP ... insight and vital guidance for publishing dissertations or DNP projects. A Nurse’s Step-by-Step Guide ... bookshelf and will be shared with new graduates and colleagues alike.” , -Nancy ...
(Date:11/11/2019)... ... November 11, 2019 , ... Thermal Product Solutions, a global ... Depyrogenation Sterilizers to the Pharmaceutical Industry. The units will be used for ... with work chamber dimensions of 36” W x 36” D x 53” H. ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... improved foodborne illness prevention and urges increased adoption of compliance technology in the ... of vegetable products sold to select retailers in the United States and Canada ...
(Date:11/9/2019)... ... November 08, 2019 , ... The Women’s Dermatologic Society (WDS) announced ... concerns. The WDS Board of Directors appointed Molly Hinshaw, MD to fill the remainder ... March 2019-March 2020 term and will be presented to the membership as the 2020-2021 ...
(Date:11/9/2019)... YORK (PRWEB) , ... November 09, 2019 , ... On ... the story of a retired and disabled 64-year-old New Yorker who recently faced homelessness. ... moved her into transitional housing until she found a new home in an assisted-living ...
Breaking Medicine News(10 mins):